The commencement of Unifill sales to this new customer, whose identity remains confidential at this time, follows the initial shipment of the device to
"The Unifill syringe is the world's first and only known prefilled syringe with safety features fully integrated within the glass barrel. The Unifill syringe is essentially a primary drug container, a safety device and a sharps disposal unit all rolled into one. It is strongly positioned to help improve patient care and better protect healthcare workers at risk of contracting infectious diseases, such as HIV via needlestick injuries and other potential transmission modes.
"We are pleased with the strong level of interest in the Unifill syringe from a significant number of pharmaceutical and biotechnology companies that recognize its potential to optimize the lifecycles of their injectable drugs and generate powerful brand differentiation within competitive therapeutic classes. We look forward to entering into agreements with a number of additional pharmaceutical partners over the coming months."
This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause
actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our Annual Report on Form 10-K and those described from time to time in other reports which we file with the
Investor Contacts (US):
Investor Contacts (Australia)
Todd Fromer / Garth Russell
KCSA Strategic Communications
Carpe DM Inc
P: + 1 212-682-6300
P: + 1 908 469 1788
P: + 61 2 8346 6500
News Provided by Acquire Media